Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
53.88 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.399 | 0.64 | 0 | 0.346 | 0.988 | 2.679 | 0.709 | 0.458 | 0.439 | 3.131 | 1.078 | 0 | 0 | 0 | 0 | 0 | 0 | 0.071 | 0.321 | 0.505 | 0 | 0.367 | 0.781 | 0.548 | 0.657 | 0.442 | 0.528 | 0.64 | 0.832 | 0.045 |
| Cost of Revenue
| 0.753 | 0.474 | 0.262 | 0.273 | 0.398 | 0.398 | 0.388 | 0.351 | 0.315 | 0.335 | 1.077 | 0.319 | 0.313 | 0.304 | 16.83 | 13.699 | 12.607 | 13.862 | 12.143 | 11.823 | 10.285 | 7.255 | 7.651 | 6.886 | 5.222 | 4.72 | 2.562 | 2.523 | 2.083 | 2.065 |
| Gross Profit
| -0.354 | 0.166 | -0.262 | 0.073 | 0.59 | 2.281 | 0.321 | 0.107 | 0.124 | 2.796 | 0.001 | -0.319 | -0.313 | -0.304 | -16.83 | -13.699 | -12.607 | -13.791 | -11.822 | -11.318 | -10.285 | -6.888 | -6.87 | -6.338 | -4.565 | -4.278 | -2.034 | -1.883 | -1.251 | -2.02 |
| Gross Profit Ratio
| -0.887 | 0.259 | 0 | 0.211 | 0.597 | 0.851 | 0.453 | 0.234 | 0.282 | 0.893 | 0.001 | 0 | 0 | 0 | -237,042,253,521,125.8 | -2,882,786,194.286 | 0 | -194.239 | -36.829 | -22.412 | 0 | -18.768 | -8.796 | -11.566 | -6.948 | -9.679 | -3.852 | -2.942 | -1.504 | -44.889 |
| Reseach & Development Expenses
| 57.591 | 52.867 | 45.318 | 43.839 | 40.64 | 38.468 | 36.991 | 31.987 | 32.995 | 28.252 | 24.604 | 21.58 | 20.487 | 17.584 | 16.83 | 13.699 | 12.607 | 13.862 | 12.143 | 11.823 | 10.285 | 7.255 | 7.651 | 6.886 | 5.222 | 4.72 | 2.562 | 2.523 | 2.083 | 2.065 |
| General & Administrative Expenses
| 24.838 | 20.828 | 17.078 | 15.484 | 13.343 | 12.189 | 11.274 | 11.925 | 10.489 | 8.706 | 7.362 | 6.227 | 5.602 | 5.334 | 4.961 | 4.752 | 4.322 | 3.991 | 3.392 | 3.911 | 3.06 | 3.156 | 2.561 | 1.732 | 1.118 | 1.248 | 0.467 | 0.491 | 0.392 | 0.589 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 24.838 | 20.828 | 17.078 | 15.484 | 13.343 | 12.189 | 11.274 | 11.925 | 10.489 | 8.706 | 7.362 | 6.227 | 5.602 | 5.334 | 4.961 | 4.752 | 4.322 | 3.991 | 3.392 | 3.911 | 3.06 | 3.156 | 2.561 | 1.732 | 1.118 | 1.248 | 0.467 | 0.491 | 0.392 | 0.589 |
| Other Expenses
| -0.013 | -0.251 | 0.04 | 2.516 | -0.091 | 1.983 | 2.565 | 0.029 | -0.081 | 0.017 | 0.094 | -0.068 | -0.029 | -0.013 | 0.15 | 0.009 | 0.178 | -0.134 | 0.665 | -0.036 | -0.042 | 0.018 | 0.936 | -0.052 | -0.036 | -0.002 | -0.025 | -0.012 | -0.009 | -0.002 |
| Operating Expenses
| 82.429 | 73.695 | 62.396 | 59.323 | 53.983 | 50.657 | 48.265 | 43.912 | 43.484 | 36.958 | 31.966 | 27.807 | 26.089 | 22.918 | 21.791 | 18.451 | 16.929 | 17.782 | 15.214 | 15.229 | 13.345 | 10.044 | 9.431 | 8.07 | 5.683 | 5.526 | 2.501 | 2.374 | 1.643 | 2.609 |
| Operating Income
| -83.182 | -74.169 | -62.658 | -58.977 | -52.995 | -47.978 | -47.556 | -43.454 | -43.045 | -33.827 | -30.888 | -27.807 | -26.089 | -22.918 | -21.791 | -18.451 | -16.929 | -17.782 | -15.214 | -15.229 | -13.345 | -10.044 | -9.431 | -8.07 | -5.683 | -5.526 | -2.501 | -2.374 | -1.643 | -2.609 |
| Operating Income Ratio
| -208.476 | -115.889 | 0 | -170.454 | -53.639 | -17.909 | -67.075 | -94.878 | -98.052 | -10.804 | -28.653 | 0 | 0 | 0 | -306,915,492,957,746.56 | -3,882,786,195.286 | 0 | -250.451 | -47.396 | -30.156 | 0 | -27.368 | -12.076 | -14.726 | -8.65 | -12.502 | -4.737 | -3.709 | -1.975 | -57.978 |
| Total Other Income Expenses Net
| 9.127 | 7.239 | 2.561 | 1.519 | -0.091 | 1.983 | 2.565 | 1.529 | 0.67 | -0.8 | 0.094 | -0.068 | -0.029 | -0.013 | 0.15 | 0.009 | 0.178 | -0.134 | 0.665 | -0.036 | -0.042 | 0.018 | 0.936 | -0.052 | -0.036 | -0.002 | -0.025 | -0.012 | -0.009 | -0.002 |
| Income Before Tax
| -74.055 | -66.93 | -60.097 | -57.458 | -50.979 | -45.995 | -44.991 | -41.925 | -42.375 | -34.627 | -30.794 | -27.851 | -26.095 | -22.901 | -21.641 | -18.32 | -16.491 | -17.36 | -14.549 | -14.43 | -12.427 | -9.016 | -8.495 | -7.588 | -5.568 | -5.464 | -2.521 | -2.382 | -1.648 | -2.606 |
| Income Before Tax Ratio
| -185.602 | -104.578 | 0 | -166.064 | -51.598 | -17.169 | -63.457 | -91.539 | -96.526 | -11.059 | -28.566 | 0 | 0 | 0 | -304,802,816,901,408.5 | -3,855,218,855.219 | 0 | -244.507 | -45.324 | -28.574 | 0 | -24.567 | -10.877 | -13.847 | -8.475 | -12.362 | -4.775 | -3.722 | -1.981 | -57.911 |
| Income Tax Expense
| 0 | -0 | 0.218 | -0.273 | -2.107 | -1.983 | -2.565 | -1.529 | -0.67 | 0.8 | -107.627 | -0.024 | -0.023 | -0.03 | -0.225 | -0.122 | -0.26 | -0.556 | -0.229 | -0.835 | -0.96 | -1.01 | -0.208 | -0.052 | -0.036 | -0.002 | -0.024 | -0.01 | -0.006 | 0 |
| Net Income
| -74.055 | -66.93 | -60.097 | -57.458 | -50.979 | -44.012 | -42.426 | -40.396 | -41.705 | -35.427 | -30.794 | -27.851 | -26.095 | -22.901 | -21.641 | -18.32 | -16.491 | -17.36 | -14.549 | -14.43 | -12.427 | -9.016 | -8.495 | -7.588 | -5.568 | -5.464 | -2.521 | -2.382 | -1.648 | -2.606 |
| Net Income Ratio
| -185.602 | -104.578 | 0 | -166.064 | -51.598 | -16.429 | -59.839 | -88.201 | -95 | -11.315 | -28.566 | 0 | 0 | 0 | -304,802,816,901,408.5 | -3,855,218,855.219 | 0 | -244.507 | -45.324 | -28.574 | 0 | -24.567 | -10.877 | -13.847 | -8.475 | -12.362 | -4.775 | -3.722 | -1.981 | -57.911 |
| EPS
| -0.94 | -0.93 | -0.9 | -1.01 | -0.94 | -0.82 | -0.79 | -0.75 | -0.79 | -0.75 | -0.68 | -0.73 | -0.7 | -0.69 | -0.66 | -0.56 | -0.53 | -0.71 | -0.6 | -0.6 | -0.51 | -0.37 | -0.35 | -0.38 | -0.25 | -0.25 | -0.18 | -0.17 | -0.12 | -0.19 |
| EPS Diluted
| -0.94 | -0.93 | -0.9 | -1.01 | -0.94 | -0.82 | -0.79 | -0.75 | -0.79 | -0.74 | -0.68 | -0.73 | -0.7 | -0.69 | -0.66 | -0.56 | -0.53 | -0.71 | -0.6 | -0.6 | -0.51 | -0.37 | -0.35 | -0.38 | -0.25 | -0.25 | -0.18 | -0.17 | -0.12 | -0.19 |
| EBITDA
| -82.429 | -73.695 | -62.396 | -58.977 | -52.715 | -47.978 | -47.556 | -43.206 | -42.861 | -33.587 | -30.888 | -27.574 | -25.859 | -22.694 | -21.791 | -18.207 | -16.685 | -17.547 | -15.214 | -15.001 | -13.168 | -9.791 | -9.431 | -7.449 | -5.492 | -5.416 | -2.472 | -2.352 | -1.62 | -2.577 |
| EBITDA Ratio
| -206.589 | -115.148 | 0 | -170.454 | -53.355 | -17.909 | -67.075 | -94.336 | -97.633 | -10.727 | -28.653 | 0 | 0 | 0 | -306,915,492,957,746.56 | -3,831,439,393.939 | 0 | -247.141 | -47.396 | -29.705 | 0 | -26.678 | -12.076 | -13.593 | -8.359 | -12.253 | -4.682 | -3.675 | -1.947 | -57.267 |